Prana recruiting for Alzheimer's drug trial

12/15/2011 | MarketWire

Prana Biotechnology said it has started screening patient participants for a Phase II imaging trial of its experimental Alzheimer's disease drug PBT2. The trial will use PiB-PET imaging and blood tests to determine the effects of the drug.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA